Introduction
Approximately 20% of all gene therapy clinical trials, registered with the NIH Recombinant DNA Advisory Committee, use replication-deficient or conditionally replicating adenovirus (Ad) vectors (Office of Recombinant DNA Database). While some successes have been reported, especially in the area of tumor management, 1, 2 the use of adenovirus gene delivery vectors has been hampered by host inflammatory responses to the virus or encoded transgene products. 3 In addition, some cell types lack either the Ad attachment receptor, CAR (Coxsackie adenovirus receptor) 4, 5 or integrins ␣v␤3 and ␣v␤5 which serve as virus internalization receptors. 6 For example, clinical trials for the treatment of cystic fibrosis reported variable, generally low, efficacy 7, 8 using adenoviral vectors due to the fact that airway epithelia do not express CAR and integrins on their apical surface. 9, 10 To increase the efficiency of Ad-mediated gene delivery and/or expand the repertoire of cells transduced, several investigators have modified outer capsid proteins of this virus. [10] [11] [12] [13] [14] [15] [16] While these studies have shown increased gene delivery, it is not clear whether specific virus modifications improved gene delivery by enhancing virus attachment and/or entry.
Adenovirus internalization via the clathrin-coated pit ization, were fused to a monoclonal antibody specific for the viral penton base. Ad vectors complexed with these bifunctional mAbs increased gene delivery 10 to 50-fold to human melanoma cells lacking ␣v integrins. The bifunctional mAbs also enhanced gene delivery by fiberless adenovirus particles which cannot bind to CAR. Improved gene delivery correlated with increased virus internalization and attachment as well as PI3K activity. The use of bifunctional mAbs to trigger specific cell signaling pathways offers a widely applicable method for bypassing the normal Ad receptors in gene delivery and potentially increasing the selectivity of gene transfer. Gene Therapy (2000) 7, 1593-1599.
pathway 17, 18 requires activation of several signaling molecules including phosphatidylinositol 3-OH kinase (PI3K) 19 and the Rho family of small GTPases. 20 The major downstream target of this signaling pathway is the actin cytoskeleton which promotes virus uptake. Recent evidence suggests that remarkably similar signaling pathways are activated by integrins and some growth factors/cytokines. 21, 22 Importantly, ligation of several growth factors/cytokine receptors, including tumor necrosis factor ␣ (TNF-␣), 23, 24 insulin-like growth factor 1 (IGF-1) 25, 26 and epidermal growth factor (EGF) receptors 27 initiate signaling events that converge at PI3K activation. This suggested a potential method to bypass Ad integrin interaction to facilitate gene delivery. Previously, we described a penton base monoclonal antibody, DAV-1, which recognizes the integrin binding site on adenovirus particle types 2/5. 28 Structural and functional studies revealed that this antibody binds to the penton base with high affinity but does not inhibit virus infection. We reengineered this antibody by fusing its heavy chain with one of several different cytokines/growth factors known to activate PI3K and expressed these fusion proteins in insect cells. These bifunctional antibody molecules retained immunoreactivity and cytokine function. Recombinant adenovirus complexed with these bifunctional antibodies increased gene delivery to cells lacking ␣v integrins, events associated with PI3K activation. Moreover, bifunctional antibodies allowed gene delivery by a fiberless Ad vector that lacks the ability to bind CAR.
Results
Analysis of bifunctional signaling antibodies DAV-1 bifunctional signaling antibodies, designated DT (DAV-1 fused to TNF-␣) (Figure 1a) , DI (DAV-1 fused to IGF-1), and DE (DAV-1 fused to EGF), were expressed in insect cells as secreted proteins and purified on Protein L affinity columns. The DT heavy chain (D H T) had an apparent molecular weight of approximately 70 kDa (Figure 1b) , consistent with the combined sizes of the DAV-1 ␥ heavy chain (53 kDa) and the monomeric TNF-␣ (17 kDa). As expected, the light chains of DAV-1 (D L ) were identical to that of the recombinant DT molecule (approximately 25 kDa). Western blot analyses showed that the DAV-1 mAb (D) and the DT molecules ( Figure  1c , upper panel) were both recognized by an anti-mouse IgG antibody, while only the DT molecule was recognized by an anti-TNF-␣ polyclonal antibody (Figure 1c,  lower panel) .
In further studies, we found that DT molecules were capable of binding to immobilized penton base or Ad particles in an ELISA and elicited cytotoxicity against a TNF-␣-sensitive cell line, MCF-7 (data not shown). These findings indicated that the DT bifunctional molecule retained both virus and cytokine receptor binding functions.
Bifunctional antibodies promote Ad-mediated gene delivery to ␣v integrin-negative melanoma cells To investigate whether DT molecules could enhance adenovirus infection of cells lacking ␣v integrins, we preincubated a first generation adenovirus vector containing a RSV-driven LacZ reporter gene with DT, at a ratio of about 2 antibody molecules per RGD motif. This complex was then added to M21-L12 human melanoma cells which do not express ␣v integrins 29 but can support efficient virus binding. 6 
SDS-PAGE (b) or transferred to a PVDF membrane filter after being separated on a 6% SDS-PAGE and immunoblotted with an anti-mouse IgG antibody (c, upper panel) or a polyclonal anti-human TNF-␣ antibody (c, lower panel). For immunoblotting, the D and DT molecules were electrophoresed under non-reducing conditions before transfer.
gene delivery by DT was not due to increased activation of the RSV LTR transgene promoter as a consequence of ligation of the TNF receptor, since M21-L12 cells that had been infected with adenovirus alone for 3 h followed by addition of DT showed very little increase in gene delivery at 48 h after infection (Figure 2e ). This result suggested that bifunctional molecules increase adenovirus-mediated gene delivery by enhancing one or more steps associated with cell entry. We next examined whether DT molecules potentiated internalization of 125 I-labeled virus particles as measured by resistance to trypsin digestion. As demonstrated in earlier studies, 6 M21-L12 cells supported relatively low levels of adenovirus internalization due to the absence of ␣v integrins. In contrast, DT molecules significantly increased the rate and extent of adenovirus internalization into these cells (Figure 3c ). Together, these findings indicate that DT molecules enhance gene delivery by promoting virus binding as well as virus internalization.
DT molecules enhance Ad binding and internalization
DT enhancement of gene delivery is associated with PI3K activation Efficient Ad internalization via ␣v integrins requires activation of PI3K, a key cell signaling molecule. To examine whether DT enhancement of gene delivery also involves PI3K, we treated M21-L12 cells with PI3K inhibitors, wortmannin or LY292004 before virus infection. Wortmannin and LY294002 inhibited Ad-mediated gene delivery by approximately 70% and 50% (Figure 4a) , respectively, indicating that PI3K activity plays a major role in DT enhancement of gene delivery.
To explore further the role of PI3K-dependent signaling in enhanced gene delivery, we measured Admediated gene delivery by other bifunctional molecules whose cytokine/growth factor domains are known to activate PI3K. DT, DE and DI molecules enhanced gene delivery by approximately 30-, 10-and 5-fold, respectively. Enhanced gene delivery by these molecules was also inhibited by pretreatment of cells with wortmannin ( Figure 4b ). These findings, combined with our earlier observation, 19 suggest that signal transduction pathways can be utilized to improve Ad-mediated gene delivery to cells that lack ␣v integrin expression. 
Bifunctional molecules allow gene delivery by fiberless adenovirus particles
In previous studies we reported the construction of a fiberless adenovirus vector which cannot bind to CAR. While the structure of these particles is nearly identical to that of wild-type virions, 30 it was not entirely clear whether these particles could be retargeted for gene delivery. 31 We therefore investigated whether DT molecules could enhance gene delivery by fiberless viruses. As previously reported, 30 fiberless particles mediated less than 2% transgene delivery to ␣v integrin-expressing SW480 epithelial cells (Figure 5a ) and almost no delivery Gene Therapy to ␣v integrin-negative M21-L12 cells (Figure 5b ). In contrast, fiberless particles complexed with DT (Figure 5a and b) delivered transgenes to 15-20% cells. Interestingly, the increased gene delivery was independent of fiber receptor expression since pre-incubation of both cells with recombinant fiber protein did not block DT enhanced gene delivery to those cells. On the other hand, pre-incubation of cells with the anti-TNF-␣ antibody or co-incubation of the Ad/DT complex with native DAV-1 significantly blocked DT enhanced gene delivery. These findings indicate that signaling antibodies can target Ad completely independent of the expression of primary Ad receptors. Furthermore, fiberless particles can be retargeted to cells via signal transducing antibodies.
Figure 4 DT enhancement of gene delivery is mediated by PI3-kinase. (a) M21-L12 melanoma cells were pretreated with the PI3K inhibitors wortmannin (30 nm) or LY292004 (20 m) for 30 min before the addition of Ad.RSV.␤gal complexed with D or DT molecules. Ad-mediated gene delivery was analyzed 48 h after infection. (b) Bifunctional antibodies that target PI3K signaling pathways (DT, DAV-1-TNF; DE, DAV-1-EGF; DI, DAV-1-IGF-1) also enhance Ad-mediated gene delivery to M21-L12 cells, and treatment with wortmannin (30 nm) for 30 min before Ad infection blocked bifunctional antibody-enhanced gene delivery. Solid bar: untreated; striped bar: wortmannin treated (mean ± s.d. of duplicate or triplicate samples).

Figure 5 Bifunctional antibodies promote gene delivery by a fiberless Ad vector. (a) Human colorectal carcinoma SW480 cells that express CAR and ␣v integrin, (b) or human melanoma M21-L12 cells that express CAR but no ␣v integrins were infected with a fiberless adenovirus or fiberless virus complexed with DT molecules (MOI of 10 4 particles per cell). The reporter gene expression was examined by ␤-gal
Discussion
Adenoviral vectors hold much promise for therapeutic applications. However, their usefulness is limited, on the one hand, by the widespread tissue distribution of CAR which restricts delivery to specific cell types and, on the other hand, by the absence of CAR and/or ␣v integrin receptors on certain cells in vivo. Studies carried out in a number of laboratories have attempted to overcome these limitations by modifying one or more of the Ad outer capsid proteins in order to retarget vectors to different cell receptors. While these studies demonstrated significant improvements in gene delivery, the underlying factors that promote gene delivery have not been clearly defined, a situation that has impeded further progress in Ad vector development.
In earlier studies we demonstrated that adenovirus cell entry via ␣v integrins requires specific signaling events involving the lipid kinase, PI3K. 19 In order to substantiate the role of PI3K in adenovirus endocytosis and gene delivery, we produced several bifunctional antibody molecules and examined whether these could facilitate PI3K activation and improve gene delivery. The studies demonstrated that Ad complexed with bifunctional antibodies significantly increased gene delivery to human melanoma cells lacking ␣v integrins and this was associated with both increased virus binding and internalization (Figure 3a, b) . Although, it has been observed that activated ␣5␤1 integrin can also improve Ad-mediated gene delivery to melanoma cells, 32 the enhanced gene delivery by DT molecules is unlikely to be caused by the ␤1 integrins since treatment of M21-L12 melanoma cells or HEK 293 kidney epithelial cells with recombinant TNF-␣ or bifunctional antibody DT did not increase ␤1 integrinmediated cell adhesion to fibronectin (data not shown). Importantly, PI3K activation played a key role in this process as we observed significant reduction in delivery following treatment of cells with pharmacologic inhibitors of PI3K (Figure 4) . Moreover, bifunctional molecules displaying distinct growth factor ligands, each of which is known to activate PI3K, also enhanced gene delivery. The variability in gene delivery by different bifunctional antibodies is most likely to be due to differences in the expression of growth factor/cytokine receptors on different cell types or to the extent of PI3K activation induced by each ligand.
Achieving gene delivery to specific cell types has been hampered by the fiber receptor (CAR) which is expressed on multiple cell types. To circumvent this problem, we investigated gene delivery by a fiberless adenovirus vector retargeted with bifunctional antibodies. Although one previous study reported that fiberless virus particles were defective in cell entry and in the maturation of certain viral structural proteins, 31 we have not observed major defects. 30 Moreover, we detected significant enhancement of gene delivery by a fiberless adenovirus complexed with several different bifunctional antibodies (data not shown). These studies confirm the structural and functional integrity of fiberless adenovirus particles and indicate their potential use for retargeting in gene delivery.
It is also possible that the PI3K-dependent signaling pathway might also be useful for increasing the uptake of other viral vectors. In this regard, adeno-associated virus (AAV) has also been reported to use ␣v integrins for infection. 33 The fact that multiple bacterial 34 and viral pathogens use integrins and/or PI3K activation for host cell invasion suggests that targeting of PI3K-dependent signaling pathways could also be used as a general scheme for potentiating cell entry of nonviral vectors.
Materials and methods
Adenovirus, antibodies, cell lines, and transfection protocols Adenovirus type 2 (Ad2; ATCC, Rockville, MD, USA) was propagated in A549 epithelial cells and purified as previously described. 6 The Ad.RSV.␤-gal and fiber genedeleted fiberless Ad (Ad.␤-gal/⌬F) vector have been described. 30 Ad2 was radiolabeled with Na 125 I using Iodogen beads (Pierce, Rockford, IL, USA). The ␣v integrin-negative M21-L12 cell line 29 was kindly provided by Dr David Cheresh (TSRI). The SF-9 insect cells (Invitrogen, Carlsbad, CA, USA) were transfected with 3 g plasmid DNA using 15 l Superfect (Qiagen, Valentia, CA, USA) in 200 l DMEM (serum-free) at room temperature for 15 min and then added to fresh cultures of SF-9 cell monolayers (about 90% confluency). Transfected cells were then subjected to Zeocin selection (600 g/ml) for the production of bifunctional antibodies using a penton base ELISA assay. A pool of positive cells was used for the production of fusion proteins. Rabbit anti-mouse antibodies conjugated to HRP and goat anti-rabbit antibodies conjugated to HRP were from Sigma (St Louis, MO, USA). The anti-human TNF-␣ antibodies were obtained from Chemicon (Temecula, CA, USA). The recombinant adenoviral penton base and fiber proteins, prepared from insect cells, were described previously. 6 Cloning of DAV-1 cDNA and construction of bifunctional antibodies Total RNA was isolated from the DAV-1 hybridoma cell line (Trizol reagent, Gibco BRL, Rockville, MD, USA) and cDNA was generated using the Superscript Plasmid System kit (Gibco BRL), essentially as described. 35 The DAV-1 heavy chain was PCR amplified with: primers 5Ј-CCT GCT CTG TGT TTA CAT GAG GG (CH3 region); 5Ј-CCC AGG GTC ACC ATG GAG TTA G (CH1 region); for kappa chain amplification: 5Ј-AAG ATG GAT ACA GTT GGT GC (CL-A), 5Ј-TGT CAA GAG CTT CAA CAG GA (CL-B) were used ( 94°C, 1 min, 63°C, 1 min, 72°C, 1 min for 30 cycles). The PCR products were ligated into pCR2.1 using a TA cloning kit from Invitrogen for sequencing purposes. Nucleotide sequences were determined by automated sequencing, and further amplification to obtain the complete heavy and light chains was performed by standard PCR reactions.
To generate secreted antibody fusion proteins, the cDNA encoding the ␥-heavy and -light chains of (DAV-1) were subcloned into the pIZ expression vector which contains a Zeocin selection marker for expression in insect cells (Invitrogen). The resulting vectors were designated as pIZ-␥, pIZ-for heavy chain and light chain constructs, respectively. FabЈ 2 forms of the DAV-1 antibody were also PCR amplified by creating a C-terminal deletion in the DAV-1 ␥-heavy chain at an amino acid position. An expression vector encoding the mature peptide of human TNF-␣ was used to create the DAV-1 mAb fusion partner by insertion into at the 3Ј end of the ␥-heavy chain in pIZ-␥. For construction of other fusion proteins, sequences encoding the mature peptides of human IGF-1 or EGF were ligated into the EcoRI site downstream of the DAV-1 heavy chain. The orientation was determined by PCR analysis. All sequences were confirmed using automated DNA sequencer.
The heavy chain-TNF-␣ and the light chain expression vectors were cotransfected into SF-9 insect cells and a pool of Zeocin-resistant cells was then selected for antibody production.
Purification and functional analysis of bifunctional antibodies Supernatants from transfected Sf-9 cells were assayed for bifunctional antibody production by an ELISA assay using an immobilized penton base as previously described. 36 Bound antibody was detected with HRP-conjugated rabbit anti-mouse antibody (whole molecule). Culture supernatants that tested positive for the bifunctional antibody were passed through a Protein L (Actigen, Cambridge, UK) affinity column. Bound antibody was eluted with either 50 mm diethylamine (pH 9.7) or 0.1 m citrate-0.15 m NaCl (pH 3.0), and pooled fractions were dialyzed against PBS (10 mm sodium phosphate, 150 mm NaCl, pH 7.2). The purified fusion proteins were further characterized by SDS-PAGE and Western blot.
The cytotoxic activity of the DT bifunctional monoclonal antibodies resulting from their interaction with TNF-␣ receptors were assayed using the TNF-sensitive MCF-7 cell line as previously described. 37 Sf-9 cell supernatants or the purified bifunctional proteins were separated on 12% SDS-PAGE gels and either stained with Coomassie blue or transferred to PVDF membrane filters (Millipore, Bedford, MA, USA) and probed with rabbit anti-mouse or goat anti-TNF-␣ antibodies followed by secondary antibodies conjugated to horseradish peroxidase and detection with a chemiluminescence reagent (Supersignal, Pierce, Rockford, IL, USA).
Adenovirus-mediated gene delivery and internalization assays An E1-deleted, or the E1 and the fiber gene-deleted fiberless adenovirus 30 encoding LacZ was incubated with DAV-TNF or control antibodies at various ratios at room temperature for 30 min (a ratio of about two bifunctional antibody molecules per RGD motif of Ad was found to be optimal for gene delivery studies). This complex was then chilled on ice before being mixed with about 1 × 10 6 M21-L12 cells on ice for another 60 min. Unbound virus was removed by washing with ice-cold PBS, and the cells were warmed to 37°C for varying times and then plated in tissue culture plates. Ad-mediated gene transfer was examined 24 or 48 h after infection by staining for ␤-galactosidase activity. 19 Briefly, the melanoma M21-L12 cells, or SW480 cells detached with trypsin-EDTA were fixed with 3% paraformaldehyde at RT for 10 min. After being washed with PBS three times, infected cells were stained with a solution that contains 50 mm Tris-HCl (pH 7.4), 143 mm NaCl, 3 mm K 3 Fe(CN) 6 , 3 mm K 4 Fe(CN) 6 , 1.5 mm CaCl 2 , and 400 g/ml of X-gal at 37°C for 2-6 h. Positive cells for ␤-gal staining were counted under a microscope. Infectivity or gene delivery efficiency was expressed as a percentage of positive cells in total cells counted. The experiments were performed in duplicate or triplicate at least three times, and the data were expressed as mean ± s.d.
To measure virus endocytosis, cells, in duplicate or triplicate samples, were incubated with complexed 125 Ilabeled adenovirus and DAV-TNF or control antibodies, in serum-free DMEM supplemented with 0.5% purified bovine serum albumin (BSA) at 4°C for 60 min. After removal of non-bound virus by washing with ice-cold PBS, the cells were warmed to 37°C for varying times. Uninternalized virions were removed by incubation with 1× tissue culture trypsin-EDTA (Gibco) at room temperature for 5-10 min before counting radioactivity in the cell pellets using a ␥-counter. The data were expressed as mean ± s.d.
